2094O SKYSCRAPER-07: A phase III, randomised study of atezolizumab (atezo) with or without tiragolumab (tira) in patients (pts) with unresectable esophageal squamous cell carcinoma (ESCC) that has not progressed following definitive concurrent chemoradiotherapy (dCRT)
作者
Ian Chau,B.C. Cho,M-H. Chen,K. Muro,Lucjan Stanislaw Wyrwicz,B. Li,S. Gao,C-H. Hsu,Anthony Turpin,Florian Lordick,Edward Cha,Qiong Wu,Suzy Kim,Jinquan Cai,Lei Zhang,Jiawen Fan,Li Wang,Karyn A. Goodman,Manish A. Shah,R-H. Xu
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2025-09-01卷期号:36: S1101-S1102被引量:11